P2X3, receptor antagonists for treatment of pain

Details for Australian Patent Application No. 2010229144 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Burgey, Christopher S.; Crowley, Brendan M.; Deng, Zhengwu J.; Paone, Daniel V.; Potteiger, Craig M.

Agent Spruson & Ferguson

Pub. Number AU-B-2010229144

PCT Pub. Number WO2010/111060

Priority 61/210,778 23.03.09 US

Filing date 15 March 2010

Wipo publication date 30 September 2010

Acceptance publication date 12 July 2012

International Classifications

A61K 31/16 - Amides, e.g. hydroxamic acids

A61K 31/405

A61K 31/415 - 1,2-Diazoles

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/111060 Priority application(s): WO2010/111060

12 July 2012 Application Accepted

  Published as AU-B-2010229144

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229147-Amino ester derivatives, salts thereof and methods of use

2010229142-P2X3, receptor antagonists for treatment of pain